Alvin Wells, MD, PhD, FACR
Director
American Medical Group
Destin, Florida, United States
Disclosure(s): Abbvie: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Amgen: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); ANI: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); AstraZeneca: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Aurinia: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Eli Lilly: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); GlaxoSmithKlein(GSK): Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Mallinkrodt: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Sanofi: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated)
Priya Reddy, MD
Physician
AARA - Southwest Florida Rheumatology
Riverview, FL, United States
Disclosure(s): AbbVie/Abbott: Advisor or Review Panel Member (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Amgen: Advisor or Review Panel Member (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Aqtual: Advisor or Review Panel Member (Terminated, December 31, 2024), Grant/Research Support (Terminated, December 31, 2024); Bristol-Myers Squibb(BMS): Advisor or Review Panel Member (Ongoing), Grant/Research Support (Ongoing); Eli Lilly: Advisor or Review Panel Member (Ongoing), Grant/Research Support (Ongoing); Exagen: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, December 31, 2024); Janssen: Grant/Research Support (Ongoing); Novartis: Advisor or Review Panel Member (Terminated, September 1, 2024); Pfizer: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Sanofi: Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Scipher: Advisor or Review Panel Member (Terminated, December 31, 2024); UCB: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
This session will introduce practicing rheumatologists to the transformative potential and the pitfalls of artificial intelligence and specifically large language models (LLMs) for routine clinical tasks. Attendees will learn of different techniques to optimize their use of LLMs, including prompt engineering, chain-of-thought prompting, few-shot-learning, and retrieval-augmented generation for day-to day documentation activities, such as drafting prior authorization requests, writing medical appeal letters, and generating patient-friendly education materials in different languages. The session will look at both advantages and disadvantages to utilizing AI in the form of a debate where one speaker will speak to the pros and the other speaker will address the challenges, or cons, to AI in the clinical setting.
Speaker: Jeffrey R. Curtis, MD, MS, MPH – University of Alabama at Birmingham
